Brief: Immunome Announces Formation Of Antibody-Drug Conjugate And T Cell Redirection Advisory Board
08/02/2023 13:11
Feb 8 (Reuters) - Immunome Inc IMNM.O :
* IMMUNOME ANNOUNCES FORMATION OF ANTIBODY-DRUG CONJUGATE
AND T
CELL REDIRECTION ADVISORY BOARD
Source text for Eikon: ID:nBw4NCJnSa
Further company coverage: IMNM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunome
See all newsBrief: Immunome - Enters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
U.S. STOCKS ON THE MOVE-Cardinal Health, Fervo Energy, Rocket Lab
U.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
Immunome climbs as Stifel initiates coverage